Koers Stellar Biotechnologies Inc Nasdaq
Aandelen
CA85855A3029
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 14,09 mln. 12,98 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -8 mln. -7,37 mln. | Nettowinst (verlies) 2025 * | -10 mln. -9,22 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-1,56
x | K/w-verhouding 2025 * |
-2,63
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 71,55% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 12-06-07 |
Michael Brooks
PSD | President | 46 | 01-09-15 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 15-07-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 07-06-19 |
Frank Oakes
BRD | Director/Board Member | 73 | 09-04-10 |
Patrick Marshall
BRD | Director/Board Member | 53 | 23-05-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,30% | 118 mld. | |
+12,15% | 106 mld. | |
-8,14% | 23,4 mld. | |
-1,25% | 21,78 mld. | |
-9,44% | 18,09 mld. | |
-41,25% | 16,72 mld. | |
-15,33% | 15,97 mld. | |
+5,80% | 14,03 mld. | |
+28,03% | 11,67 mld. |